Cargando…

Zhilong Huoxue Tongyu capsule inhibits rabbit model of hyperlipidemia and atherosclerosis through NF-κB/NLRP3 signaling pathway

OBJECTIVE: Zhilong Huoxue Tongyu capsule (ZL) is a Chinese patent medicine for treating cardio-cerebral diseases. However, the pharmacological mechanism by which it regulates blood lipids and treats atherosclerosis (AS) is unclear. Therefore, the purpose of this study is to explore the mechanism of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Mengnan, Wang, Raoqiong, Chen, Mingtai, Hu, Zhongjing, Han, Mei, Mazhar, Maryam, Xue, Jinyi, Zou, Yuan, Wu, Qibiao, Yang, Sijin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643091/ https://www.ncbi.nlm.nih.gov/pubmed/38027979 http://dx.doi.org/10.1016/j.heliyon.2023.e20026

Ejemplares similares

Zhilong Huoxue Tongyu Capsule Alleviated the Pyroptosis of Vascular Endothelial Cells Induced by ox-LDL through miR-30b-5p/NLRP3
por: Liu, Mengnan, et al.
Publicado: (2022)

Zhilong Huoxue Tongyu Capsules' Effects on ischemic stroke: An assessment using fecal 16S rRNA gene sequencing and untargeted serum metabolomics
por: Wang, Raoqiong, et al.
Publicado: (2022)

Exploring the Ferroptosis Mechanism of Zhilong Huoxue Tongyu Capsule for the Treatment of Intracerebral Hemorrhage Based on Network Pharmacology and In Vivo Validation
por: Wang, Lixia, et al.
Publicado: (2022)

Zhilong Huoxue Tongyu capsule attenuates intracerebral hemorrhage induced redox imbalance by modulation of Nrf2 signaling pathway
por: Mazhar, Maryam, et al.
Publicado: (2023)

Gene Network Mechanism of Zhilong Huoxue Tongyu Capsule in Treating Cerebral Ischemia–Reperfusion
por: Li, Na, et al.
Publicado: (2022)

Zhilong Huoxue Tongyu Capsules Ameliorate Early Brain Inflammatory Injury Induced by Intracerebral Hemorrhage via Inhibition of Canonical NFкβ Signalling Pathway
por: Mazhar, Maryam, et al.
Publicado: (2022)

Danshen decoction in the treatment of heart failure: A systematic review and meta-analysis protocol of randomized controlled trials
por: Liu, Mengnan, et al.
Publicado: (2022)

Clinical effect of Danshen decoction in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials
por: Li, Ziyi, et al.
Publicado: (2023)

Huoxue Qianyang Qutan recipe attenuates cardiac fibrosis by inhibiting the NLRP3 inflammasome signalling pathway in obese hypertensive rats
por: Lu, Bo, et al.
Publicado: (2021)

Proteomic analysis and comparison of intra- and extracranial cerebral atherosclerosis responses to hyperlipidemia in rabbits
por: Tu, Zhi-Lan, et al.
Publicado: (2017)

Efficacy evaluation of Buyang Huanwu Decoction in the treatment of ischemic stroke in the recovery period: A systematic review of randomized controlled trials
por: Wang, Raoqiong, et al.
Publicado: (2022)

Bufei Huoxue Capsule Attenuates PM2.5-Induced Pulmonary Inflammation in Mice
por: Jing, Yue, et al.
Publicado: (2017)

Shengjie Tongyu Granule Inhibits Vascular Remodeling in ApoE-Gene-Knockout Mice
por: Chen, Min, et al.
Publicado: (2012)

Danshen Decoction in the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis Protocol of Randomized Controlled Trials
por: Liu, Mengnan, et al.
Publicado: (2022)

Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy
por: Liu, Mengnan, et al.
Publicado: (2022)

Protosappanin A protects against atherosclerosis via anti- hyperlipidemia, anti-inflammation and NF-κB signaling pathway in hyperlipidemic rabbits
por: Huang, Ying, et al.
Publicado: (2018)

Investigation on the mechanisms of guiqi huoxue capsule for treating cervical spondylosis based on network pharmacology and molecular docking
por: Liu, Yingying, et al.
Publicado: (2021)

Effectiveness and safety of modified ‘Huoxue Shugan’ formulas on coronary heart disease combined with depression: protocol for a systematic review
por: Chen, Mingtai, et al.
Publicado: (2018)

Huoxue Qianyang Qutan recipe attenuates Ang II-induced cardiomyocyte hypertrophy by regulating reactive oxygen species production
por: Gui, Mingtai, et al.
Publicado: (2021)

Network Pharmacology and In Vitro Experimental Verification Reveal the Mechanism of the Hirudin in Suppressing Myocardial Hypertrophy
por: Liu, Mengnan, et al.
Publicado: (2022)

Synergistic Network Pharmacology for Traditional Chinese Medicine Liangxue Tongyu Formula in Acute Intracerebral Hemorrhagic Stroke
por: Chen, Yang, et al.
Publicado: (2021)

Systematic Pharmacology-Based Strategy to Explore the Mechanism of Bufei Huoxue Capsule in the Treatment of Chronic Obstructive Pulmonary Disease
por: Shi, Liangtian, et al.
Publicado: (2022)

ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis
por: Mohamed, Farzahna, et al.
Publicado: (2022)

Systematic Review and Meta-Analysis of Randomized Controlled Trials of Liangxue Tongyu Formula on Patients With Acute Intracerebral Hemorrhage
por: Jiang, Chao, et al.
Publicado: (2020)

Liangxue Tongyu Prescription Alleviates Brain Damage in Acute Intracerebral Hemorrhage Rats by Regulating Intestinal Mucosal Barrier Function
por: Zhou, Yu, et al.
Publicado: (2022)

Effect of crude extract of Bombyx mori coccoons in hyperlipidemia and atherosclerosis
por: Ali, Mir Mahdi, et al.
Publicado: (2011)

Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis
por: Tummala, Ramyashree, et al.
Publicado: (2022)

Hyperlipidemia is necessary for the initiation and progression of atherosclerosis by severe periodontitis in mice
por: Suh, Jin Sook, et al.
Publicado: (2022)

Anti-Atherosclerosis and Anti-Hyperlipidemia Functions of Terminalia catappa Fruit
por: Tabansi, Doris, et al.
Publicado: (2023)

Bushen Huoxue Acupuncture Inhibits NLRP1 Inflammasome-Mediated Neuronal Pyroptosis in SAMP8 Mouse Model of Alzheimer’s Disease
por: Zhang, Ting, et al.
Publicado: (2021)

Assessing the Pharmacological and Therapeutic Efficacy of Traditional Chinese Medicine Liangxue Tongyu Prescription for Intracerebral Hemorrhagic Stroke in Neurological Disease Models
por: Li, Xun, et al.
Publicado: (2018)

Bufei huoxue capsules in the management of convalescent COVID-19 infection: study protocol for a multicenter, double-blind, and randomized controlled trial
por: Chen, Yuqin, et al.
Publicado: (2021)

Novel Nongenetic Murine Model of Hyperglycemia and Hyperlipidemia-Associated Aggravated Atherosclerosis
por: Gaul, Susanne, et al.
Publicado: (2022)

Postprandial Hyperlipidemia: Association with Inflammation and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
por: Mena-Vázquez, Natalia, et al.
Publicado: (2022)

Attenuated Combined Action of Cyclosporine A and Hyperlipidemia on Atherogenesis in Rabbits by Thymoquinone
por: Ragheb, Ahmed, et al.
Publicado: (2011)

Research Advance on Qingfei Paidu Decoction in Prescription Principle, Mechanism Analysis and Clinical Application
por: Ren, Wei, et al.
Publicado: (2021)

Testin on Atherosclerosis in Rabbits
por: Zhang, Yue, et al.
Publicado: (2015)

Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: A multicentre, double-blind, and randomised controlled trial
por: Chen, Yuqin, et al.
Publicado: (2022)

Huoxue Qianyang Qutan Recipe Protects against Early Renal Damage Induced by Obesity-Related Hypertension via the SIRT1/NF-κB/IL-6 Pathway: Integrating Network Pharmacology and Experimental Validation-Based Strategy
por: Wang, Mingzhu, et al.
Publicado: (2022)

Role of NLRP3 Inflammasomes in Atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_18q00jf41lt4gao475p243846c